Cargando…
Candidemia Following Ureteric Stent Placement in a Patient With Type 2 Diabetes Treated With Canagliflozin
A 38-year-old female patient with well-controlled type 2 diabetes mellitus treated with canagliflozin underwent ureteral stent placement for obstructive renal calculi. Ten days following ureteroscopy and ureteral stenting, she developed fevers and blood cultures grew Candida glabrata (C. glabrata)....
Autores principales: | Raj, Rishi, Hendrie, Jon, Jacob, Aasems, Adams, Derick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363659/ https://www.ncbi.nlm.nih.gov/pubmed/30761087 http://dx.doi.org/10.3389/fendo.2019.00020 |
Ejemplares similares
-
SUN-169 A Case of Candidemia in a Patient with Diabetes on Canagliflozin Following Urologic Procedure
por: Raj, Rishi, et al.
Publicado: (2019) -
Case report: SARS-CoV-2 infection as a trigger for diabetic ketoacidosis and newly detected pancreatic autoantibodies
por: Mishra, Rahul, et al.
Publicado: (2022) -
Ureterosciatic hernia treated with ureteral stent placement
por: Nakazawa, Yusuke, et al.
Publicado: (2018) -
Perinephric Hematoma Associated with Pyelonephritis Following Ureteral Stent Placement for Ureteral Obstruction Causing Hydronephrosis
por: Chung, Hac-Tu Jacqueline, et al.
Publicado: (2021) -
Isolated Adrenocorticotropic Hormone Deficiency Secondary to Chronic Opiate Use
por: Raj, Rishi, et al.
Publicado: (2020)